✦ LIBER ✦

Radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician

✍ Scribed by Peter S. Conti

Book ID: 117988029
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 34 KB
Volume: 34
Category: Article
ISSN: 0001-2998
DOI: 10.1053/j.semnuclmed.2003.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Logistics of radioimmunotherapy with Ytt

Logistics of radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin)

✍ A.Michael Zimmer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Safety and efficacy of radioimmunotherap

Safety and efficacy of radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin)

✍ Hossein Borghaei; Russell J Schilder 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 87 KB

P166 Experience with the use of yttrium-

P166 Experience with the use of yttrium-90 ibritumomab tiuxetan (Zevalin) in relapsed follicular lymphoma

✍ J. Demeter; K. Balassa; M. D¨om¨ot¨or; M. Egyed; Z. Gasztonyi; H. Aryab; M. Gurz 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

cursor was set to the same position in each sample, where 5% of T/NK cells were Zap-70 negative. Zap-70 and CD38 labeling was determined on CD19+ cells. Results: With dichotomized evaluation of CD38 and Zap-70 expression 70% of the cases showed concordant results: 32% were Zap-70+/CD38+ and 38% were

Yttrium-90 Ibritumomab Tiuxetan as a Sin

Yttrium-90 Ibritumomab Tiuxetan as a Single Agent in Patients With Pretreated B-Cell Lymphoma: Evaluation of the Long-Term Outcome

✍ Pier Luigi Zinzani; Letizia Gandolfi; Vittorio Stefoni; Stefano Fanti; Mariapaol 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 183 KB

A randomized study comparing yttrium-90

A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

✍ Avichai Shimoni; Irit Avivi; Jacob M. Rowe; Moshe Yeshurun; Itai Levi; Reuven Or 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Antilymphoma Treatments Given Subsequent

Antilymphoma Treatments Given Subsequent to Yttrium 90 Ibritumomab Tiuxetan Are Feasible in Patients with Progressive Non-Hodgkin's Lymphoma: A Review of the Literature

✍ Ansell, Stephen M.; Schilder, Russell J.; Pieslor, Peter C.; Gordon, Leo I.; Emm 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB